Oaktree Acquisition Corp. III Life Sciences
Financial ServicesNASDAQ:OACC · NASDAQ Global Market
+$0.04 today
Vol 0.00M · Avg 0.01M
Income Statement
Follow revenue through to earnings
Review sales, margins, expenses, and profit trends to see what is actually driving reported earnings over time.
Earnings Waterfall
Revenue to Net Income
Key Ratios
Analysis
$0 of revenue converted into $7.0M of net income for the selected period. Gross margin is 0.0% and net margin is 0.0%, showing how much revenue survives after costs and taxes. EPS is $0.29, tying the income statement back to per-share earnings.
Income Statement
Annual data · 2 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $776.0M | $888.0M | $1.0B |
| Cost of Revenue | $0 | $0 | $1.3B | -$1.7B | $344.8M |
| Gross Profit | $0 | $0 | $13.0B | $11.6B | $10.3B |
| Gross Margin | — | — | 17.0% | 26.4% | 45.5% |
| Research & Development | $0 | $0 | $568.8M | $1.2B | $378.4M |
| Selling, General & Admin | $1.2M +169835.6% | $704 | -$1.6B | $811.0M | $1.4B |
| Operating Expenses | $1.2M +169835.6% | $704 | $14.3B | -$15.9B | $3.6B |
| Depreciation & Amortization | $0 -100.0% | $704 | $990.2M | $419.0M | $1.2B |
| EBITDA | -$1.2M | $0 | $4.4B | $10.0B | $12.6B |
| EBITDA Margin | — | — | 18.6% | 14.3% | 10.0% |
| Operating Income | -$1.2M -169983.5% | -$703 | $10.3B | $9.0B | $10.6B |
| Operating Margin | — | — | 13.3% | 11.2% | 18.7% |
| Interest Income | $8.5M +434.0% | $1.6M | $718.6M | $875.4M | $1.3B |
| Interest Expense | $0 | $0 | $633.2M | $801.2M | $969.2M |
| Other Income / Expenses | $8.5M +251890.2% | $3.4K | $503.0M | $368.6M | -$1.6B |
| Income Before Tax | $7.3M +273607.2% | $2.7K | $12.2B | $13.9B | -$15.6B |
| Pre-Tax Margin | — | — | 7.9% | 15.4% | 13.3% |
| Income Tax Expense | $0 | $0 | $1.2B | $375.6M | $666.8M |
| Net Income | $7.3M +273607.2% | $2.7K | $5.2B | $5.1B | $5.0B |
| Net Margin | — | — | 42.3% | 47.3% | 7.4% |
| EPS (Basic) | $0 +453.5% | $0 | $1.4B | $591.2M | $1.2B |
| EPS (Diluted) | $0 +453.5% | $0 | $934.2M | $777.4M | $620.6M |
| Weighted Avg Shares | $19.2M -21.9% | $24.6M | $556.2M | $724.2M | $892.2M |
| Weighted Avg Shares (Diluted) | $19.2M -21.9% | $24.6M | $812.4M | $566.0M | $319.6M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Cartesian Growth Corporation III
NASDAQ:CGCT
$423.94M
M3-Brigade Acquisition V Corp. Class A Ordinary shares
NASDAQ:MBAV
$350.39M
Artius II Acquisition Inc. Class A Ordinary Shares
NASDAQ:AACB
$290.59M
Soulpower Acquisition Corp.
NYSE:SOUL
$265.04M
FACT II Acquisition Corp
NASDAQ:FACT
$259.02M
Perimeter Acquisition Corp. I Class A Ordinary Shares
NASDAQ:PMTR
$258.54M
Copley Acquisition Corp
NYSE:COPL
$247.25M
Rithm Acquisition Corp.
NYSE:RAC
$247.25M
Mountain Lake Acquisition Corp.
NASDAQ:MLAC
$96.70M
SEC Filings
Recent regulatory filings
No filings found.
How much revenue does OACC generate?
Oaktree Acquisition Corp. III Life Sciences (OACC) reported $0.00 of revenue in fiscal 2025.
Is OACC profitable?
Oaktree Acquisition Corp. III Life Sciences (OACC) reported $7.29M of net income.
Explore More
Continue the stock analysis
Jump to another research area for this company.